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Aspergillus fumigatus is able to invade and grow in the lungs of immunosuppressed
individuals and causes invasive pulmonary aspergillosis. The concentration of free zinc
in living tissues is much lower than that required for optimal fungal growth in vitro
because most of it is tightly bound to proteins. To obtain efficiently zinc from a living
host A. fumigatus uses the zinc transporters ZrfA, ZrfB, and ZrfC. The ZafA transcriptional
regulator induces the expression of all these transporters and is essential for virulence.
Thus, ZafA could be targeted therapeutically to inhibit fungal growth. The ZrfC transporter
plays the major role in zinc acquisition from the host whereas ZrfA and ZrfB rather
have a supplementary role to that of ZrfC. In addition, only ZrfC enables A. fumigatus
to overcome the inhibitory effect of calprotectin, which is an antimicrobial Zn/Mn-
chelating protein synthesized and released by neutrophils within the fungal abscesses
of immunosuppressed non-leucopenic animals. Hence, fungal survival in these animals
would be undermined upon blocking therapeutically the function of ZrfC. Therefore, both
ZafA and ZrfC have emerged as promising targets for the discovery of new antifungals to
treat Aspergillus infections.
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INTRODUCTION
Zinc is, after magnesium, the second most widespread metal
present in enzymes belonging to all six major functional classes
(Andreini et al., 2008). In addition, zinc ions are structural com-
ponents of DNA binding domains of many transcription regula-
tors and are required for their proper folding and binding to DNA.
Consequently, zinc is essential for a wide variety of biochemical
processes, for the adequate regulation of gene expression, and for
cellular growth and development. Thus, when the cellular zinc
content is lower than the “zinc quota,” i.e., the total amount of
zinc required for a cell to grow optimally (Outten and O’Halloran,
2001), cell growth stops. In contrast, cells become intoxicated
when the cellular zinc content exceeds an upper threshold. Like all
organisms, the filamentous fungus Aspergillus fumigatus regulates
tightly zinc homeostasis to maintain its own zinc quota. However,
unlike most saprophytic fungi, A. fumigatus has different bio-
logical traits that turn it into an opportunistic pathogen (Tekaia
and Latge, 2005), including its capacity to uptake zinc from host
tissues (Amich et al., 2014). Thus, it is able to invade the lungs of
susceptible individuals and causes invasive pulmonary aspergillo-
sis (IPA), whose mortality rate may reach up to 90% depending
on the host’s immune status (Kousha et al., 2011). One of the
reasons for this high mortality rate is the low efficiency of the
antifungal drugs currently in use to stop rapidly fungal growth. In
this regard, we propose both regulation of zinc homeostasis and
zinc acquisition as ideal therapeutic targets for the development of
a next generation of antifungals, as an alternative to the classical
antifungals that target either cell wall or ergosterol biosynthesis.
ZINC AVAILABILITY AND MYCELIAL GROWTH OF Aspergillus
fumigatus
The primary ecological niche of A. fumigatus is soil, where it
grows as a saprophyte on organic decaying matter. In soils zinc is
found in solution as free ions (Zn2+ and ZnOH+) and/or forming
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FIGURE 1 | Lungs from immunosuppressed mice infected with different
A. fumigatus strains. The mice were immunosuppressed using a
leucopenic regime and inoculated intranasally with 105 conidia of the AF14
(wild-type), AF54 (1zrfC), AF721 (1zrfA1zrfB1zrfC), and AF731
(1zrfA1zrfB1zrfC[zrfC]) strains, as described in Amich et al. (2014). Mice
were sacrificed after 4 days post-inoculation and the left lung was excised
and photographed. The lungs from mice infected with the wild-type and
1zrfABC[zrfC] strains showed the greatest signs of pulmonary infarction.
In contrast, the lungs from mice inoculated with the 1zrfC strain showed a
very low degree of infarction. The lungs from mice inoculated with the
1zrfABC strain appeared healthy similar to that from a non-inoculated
mouse used as reference.
organic zinc complexes, as exchangeable zinc adsorbed to solid
surfaces and forming insoluble complexes with other minerals
(Alloway, 2008). The concentration of zinc in the soil liquid phase
depends upon several factors but the ones that most strongly
influence zinc solubility in soils are pH and moisture. Thus,
although the concentration of soluble zinc in most soils ranges
from 0.06 to 4.2 µM, in very acid soils it may exceed 110 µM
(Alloway, 2008). Only the exchangeable zinc pool (i.e., the soluble
zinc pool and the one that can be easily desorbed or released
from soil particles) is available for plants and microorganisms.
In addition, soils are dynamic environments that undergo wide
fluctuations in many of their chemical and physical parameters
that influence zinc availability. This explains why saprophytic soil
inhabitants, particularly those adapted to grow in a wide range of
pH values (e.g., A. fumigatus), are well equipped to face variations
in soil zinc availability.
Aspergillus fumigatus has many genes encoding both zinc
importers and exporters. The predicted role in zinc homeostasis
of most of these transporters is based on what is known about
similar proteins in other fungi, plants, and bacteria (Amich and
Calera, 2014). The regulation of zinc homeostasis in A. fumigatus
is mediated by the master zinc-responsive transcription factor
ZafA (Moreno et al., 2007). In addition, the ZafA activity is
further modulated in a pH-dependent manner likely influenced
by the PacC transcriptional regulator (Amich et al., 2009, 2010).
Thus, ZafA induces the transcription of zrfA and zrfB more
strongly in acidic than in alkaline zinc-limiting media. In contrast,
ZafA induces much more strongly the transcription of zrfC in
alkaline than in acidic zinc-limiting media (Vicentefranqueira
et al., 2005; Amich et al., 2010).
Although A. fumigatus is primarily a saprophytic fungus, it can
grow also as a parasite within a susceptible, immunosuppressed
animal host. Unlike soils, where zinc availability may change dra-
matically as a result of weather, leaching, animal activities, and/or
human interventions, living environments provide homeostatic
conditions in which zinc is tightly bound to zinc-binding proteins,
such that the concentration of labile zinc in host tissues (i.e.,
the pool of free Zn2+ ions in both soluble and exchangeable
form) is in the nanomolar range (Iyengar and Woittiez, 1988).
Thus, zinc availability in living tissues is maintained constantly
too low to support a sustained growth of most microorganisms,
unless they have evolved mechanisms to overcome zinc starva-
tion during their saprophytic growth that could be adapted for
parasitic growth. In this regard, A. fumigatus takes advantage of
the zinc transporters ZrfA, ZrfB, and ZrfC to grow in the slightly
alkaline and extreme zinc-limiting environment provided by the
host.
ZINC ACQUISITION AND VIRULENCE IN A. fumigatus
AND OTHER FUNGAL PATHOGENS
The relationship between zinc homeostasis and virulence of
human fungal pathogens was shown for the first time in A. fumi-
gatus. The ZafA-mediated regulation of zinc homeostasis is essen-
tial for A. fumigatus growth within a host but dispensable for it to
grow as a saprophyte in zinc-replete media (Moreno et al., 2007).
The avirulence of a 1zafA mutant of A. fumigatus primarily
resides in its inability to obtain zinc from the host, which results in
a zinc shortage that stops germ tube elongation. This is consistent
with the avirulence of a 1zrfA1zrfB1zrfC strain (Amich et al.,
2014), which lacks the three major downstream targets of ZafA.
However, the ZrfA and ZrfB acidic zinc transporters and the
ZrfC alkaline zinc transporter contribute differentially to fungal
virulence as shown by the appearance of lungs excised from mice
infected with the1zrfA1zrfB and1zrfC mutants (Figure 1). The
ZrfC protein plays a major role in obtaining zinc from living
tissues and sustaining fungal growth within them, whereas the
acidic transporters ZrfA/B have a supplementary function in zinc
acquisition from the host. The importance of ZrfC for fungal
virulence relies on its long extracellular N-terminus, which has
four putative zinc-binding motifs and that is absent in the acidic
transporters (Amich et al., 2010, 2014). Indeed, in terms of fungal
virulence the zinc uptake activity of the ZrfC protein without
its N-terminus equals to that of ZrfA and ZrfB together (Amich
et al., 2014). ZafA-like regulatory systems have also been described
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in and related to the virulence of the pathogenic fungi Crypto-
coccus gattii, Candida albicans, and Paracoccidioides brasiliensis,
although in these latter two microorganisms this has not yet been
experimentally confirmed (Nobile et al., 2009; Schneider et al.,
2012; Parente et al., 2013). These fungal pathogens have genes
encoding proteins similar to ZrfA/B and ZrfC, although the N-
terminus of the C. gatti ZrfC-like protein (XP_003195293) is
very different from that of ZrfC and the C. albicans (XP_715421)
and P. brasiliensis (XP_010761875) ZrfC-like proteins. In either
case, the roles of these transporters for virulence have not been
investigated.
ZINC-BASED STRATEGIES DEPLOYED BY PHAGOCYTES
TO INHIBIT MICROBIAL GROWTH
The regulation of zinc homeostasis is especially relevant for
pathogens because the amount of labile zinc in host tissues is
very low. Accordingly, mammals have evolved the capacity to
inhibit microbial growth in their tissues by zinc starvation, as part
of a broader defense mechanism termed “nutritional immunity”
(Hood and Skaar, 2012). Two different strategies to sequester
labile zinc have been described in mammals thus far. One of
them is directed to inhibit the growth of extracellular pathogens
and relies upon releasing of calprotectin (CP) by neutrophils
in abscesses (Corbin et al., 2008). The other one operates in
activated macrophages infected with intracellular pathogens and
involves the binding of zinc to metallothioneins (MTs; Subra-
manian Vignesh et al., 2013). However, an excess of zinc is also
noxious for pathogens, probably because it reacts with the −SH
groups of proteins. Thus, it is not surprising that mammals had
evolved also an antimicrobial strategy based upon zinc poisoning
of microbes enclosed in macrophage endosomes (Botella et al.,
2011). These defense strategies against pathogens deployed by
mammals are consistent with the notion that zinc acquisition
and zinc detoxification are virulence attributes of bacterial and
fungal pathogens. It might be possible that both MTs and zinc
poisoning play a role in macrophages against A. fumigatus, as they
do respectively against Histoplasma capsulatum (Subramanian
Vignesh et al., 2013) and Mycobacterium tuberculosis (Botella
et al., 2011). However, the effects of MTs and zinc poisoning
on conidia germination inside the macrophages have not been
investigated. In contrast, it has been reported that CP is the major
component of the extracellular traps released by neutrophils
(NETs) as a defense against C. albicans (Urban et al., 2009). NETs
are also produced against A. fumigatus both in vitro and in vivo
(Bruns et al., 2010; McCormick et al., 2010). More recently it has
been shown that CP can reduce the growth capacity in vitro of
A. fumigatus and that the ability to grow of this fungus in the
presence of CP under alkaline Zn/Mn-limiting conditions relies
on the function of ZrfC (Amich et al., 2014). The only leukocytes
infiltrated into A. fumigatus abscesses in immunosuppressed non-
leucopenic mice that are able to produce CP are the polymor-
phonuclear neutrophils (PMNs) and plasmacytoid dendritic cells
(pDCs; a subtype of DCs). PMNs produce huge amounts of CP
that is released in NETs following their lysis (Urban et al., 2009)
whereas pDCs synthesize and transport CP to their surface upon
activation (Ramirez-Ortiz et al., 2011). In fungal abscesses heavily
infiltrated with leukocytes we have observed patches and thread-
like structures stained intensely with hematoxylin (Figure 2A).
These structures, which might correspond to chromatin present
in DCs, monocytes, PMNs, and/or NETs, are either spread out on
the surface of hyphae or enveloping them. Interestingly, the obser-
vation at high magnification of infiltrated abscesses immunos-
tained for CP indicated that this was most frequently detected
in leukocytes located in close proximity to hyphae or attached to
them (Figure 2B). This suggests that CP may create a Zn/Mn-
deprived microenvironment around fungal cells to restrict their
growth at the time that A. fumigatus manages to overcome the
inhibitory effect of CP through the action of the ZrfC. Thus, ZrfC
has a dual role in fungal virulence: it is needed to mediate zinc
uptake and to counteract the inhibitory effect of CP in abscesses.
THE REGULATION OF ZINC HOMEOSTASIS AND ZINC
ACQUISITION AS IDEAL TARGETS FOR ANTIFUNGAL
DISCOVERY AND DEVELOPMENT
The fact that host mammals are able to inhibit microbial growth
either by intoxicating pathogens with zinc or by limiting the access
of pathogens to the host zinc pool have led us to presume that
these strategies could be imitated to control therapeutically the
growth of pathogens in a host.
The lack of knowledge about whether the host immune cells
use zinc poisoning to prevent or combat A. fumigatus infections
and, in this case, whether the fungus has countermeasures to
protect itself from it, does not allow us to envision to date a
specific therapeutic approach to mimic it. In contrast, what is
known to date about zinc homeostasis is enough for us to propose
that a therapeutic approach based on preventing the access of
the fungus to host zinc would be deleterious for fungal cells
because fungal growth depends on a constant intake of zinc and
fungal zinc depletion increases the synthesis of harmful reactive
oxygen species (reviewed in Eide, 2011). Thus, any compound
that interfere intra or extracellularly with zinc homeostasis would
predictably inhibit fast and efficiently the fungal growth within
host tissues.
The major challenge to treat IPA by targeting zinc homeostasis
relies on the identification of the targets and the discovery and
development of specific antifungal compounds. Regarding the
first point, we propose the ZrfC transporter and ZafA tran-
scription factor as targets. Nutrient transporters are currently
considered as new promising therapeutic targets (Slavic et al.,
2011; Prati et al., 2014). ZrfC has a long N-terminus that has been
predicted to be located toward the extracellular side of the plasma
membrane and, hence, that would be readily accessible to specific
inhibitors (Amich et al., 2010). In addition, it would be expected
that any interference with the function of the N-terminus of ZrfC
had the same effect as inactivation of the whole protein in terms of
both fungal growth and virulence (Amich et al., 2014). However,
the inactivation of ZrfC is partially compensated by an increase
in the expression level of the acidic transporters (ZrfA and ZrfB;
Amich et al., 2014), which is most likely mediated by ZafA.
This indicates that to block efficiently fungal growth it would be
required to inhibit either ZrfA/B or ZafA in addition to ZrfC.
By taking advantage of the key role of ZafA in the homeostatic
and adaptive responses to zinc deprivation, we consider that ZafA
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FIGURE 2 | Detailed observation of the edge of A. fumigatus abscesses
heavily infiltrated with immune cells in lung sections from
non-leucopenic mice infected with a wild-type strain. The mice were
euthanized after 4 days post-inoculation. The lungs were fixed and
processed for histology and immunocytochemistry, as described in Amich
et al. (2014). The slides were stained with H&E (A) or immunostained using
an antibody against the S100A8 component (calgranulin A) of calprotectin
(B) and observed at the highest magnification using with a 100× objective.
In H&E-stained slides of lungs infected with filamentous fungi is usually
hard to distinguish between scattered hyphae and the surrounding lung
tissue. However, in abscesses with a high fungal load, hyphae are easily
recognized from the surrounding lung tissue in H&E-stained slides. In panel
(A) is shown in great detail the edge of an abscess with a heavy fungal
load. Lengthwise hyphae are indicated with red asterisks and
cross-sectioned hyphae are indicated with the “×” symbol. Yellow
arrowheads indicate haematoxylin-positive thread-like structures and
patches. The hyphae more heavily covered with haematoxylin-positive
material were typically located at the outlying region of the infectious foci
(see the inset image as a reference) and showed both a degree of
vacuolization higher and a diameter wider than those of hyphae located
toward the middle of the infectious foci (indicated with a star in the inset),
which probably anticipates their lysis. In the inset is shown about half of the
infectious focus chosen to take the picture (inset bar = 50 µm). The red
rectangle in the inset delimits the enlarged image showed in panel (A). The
area enclosed by the semicircle around the star delimits the part of the
infectious focus with the heaviest fungal load. In panel (B) calprotectin was
immunodetected either associated to immune cells (most likely pDCs
and/or neutrophils) or laid out over hyphae.
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would be an alternative target to ZrfA/B. However, to inhibit
or reduce noticeably the function of any transcription factor it
would be required to disrupt specifically either a DNA–protein or
a protein–protein interaction. To disrupt the interaction of ZafA
with DNA we should target their C2H2 zinc fingers. However,
given the highly conserved C2H2 structure of the zinc fingers
in many transcription factors from fungi to humans have led
us to think that is very unlikely to find a drug able to bind
selectively to the zinc fingers of ZafA without interfering with
human transcription factors. Thus, we propose to target the
ZafA transactivation domains to disable the specific interaction
of ZafA with the transcriptional machinery. For instance, this
mechanism of action has been reported for triptolide, which is
a natural compound that inhibits the transactivating function
of the human HSF1 transcription factor (Westerheide et al.,
2006).
Importantly, the ZafA- and ZrfC-like proteins are distributed
exclusively among fungi and no orthologs have been found
in mammals. In fact, the human MTF-1 protein (reviewed in
Gunther et al., 2012), which might be considered functionally
analogous to ZafA, is structurally unrelated to ZafA. Moreover,
the hMTF-1 regulator functions in an opposite manner to that of
ZafA. Thus, hMTF-1 induces gene expression under zinc-replete
conditions whereas ZafA induces gene expression under zinc-
limiting conditions. On the other hand, ZrfC is very distantly
related to each human ZIP protein. Indeed, it is very difficult to
infer a functional similarity of ZrfC with any of the 14 human
ZIP proteins (reviewed in Cousins et al., 2006), which suggests
that the mechanism of action of ZrfC might be disrupted without
disturbing the action of any hZIP.
The chemical compounds able to disrupt zinc homeostasis in
the fungus growing within the host could exert their effect by
either chelating zinc or by inhibiting selectively the function of
specific proteins that are essential to maintain zinc homeostasis.
The use of chelating agents has been explored as an option
for anticancer (Huesca et al., 2009; Lui et al., 2012; Zuo et al.,
2012; Fatfat et al., 2014) and antimicrobial therapies (reviewed in
Santos et al., 2012). Several studies have shown that the treatment
with different zinc chelators kills different types of cancer cells,
which suggest that zinc chelators may be theoretically useful for
the treatment of different types of cancer (Torti et al., 1998;
Hashemi et al., 2007; Huesca et al., 2009; Zuo et al., 2012).
In contrast, most evidences about the reliability of using metal
chelators for the treatment of A. fumigatus infections have arisen
from the use of iron chelators either alone or combined with
classical antifungal drugs (Zarember et al., 2009; Ibrahim et al.,
2010; Leal et al., 2013). The only study to support the notion
that zinc chelation might be useful to combat A. fumigatus
arose from the finding that EDTA is an adjunct antifungal agent
in a rodent model of IPA (Hachem et al., 2006). However,
EDTA is a broad-spectrum chelator, so whether its antifungal
effect is due to its capacity to chelate zinc and/or other metals
is unknown. Nevertheless, the survival rate of mice with IPA
increases significantly when they are treated with the zinc-specific
chelator TPEN (unpublished data), which demonstrates that a
compound able to interfere with zinc homeostasis can be useful
as antifungal drug. However, available scientific evidences do not
support claims that chelation therapies provide a safe treatment
for either cancer or infectious diseases. In this regard, it has been
reported that iron chelation has the potential risk of producing
undesired side effects in human patients by altering the normal
iron homeostasis (Kontoghiorghes et al., 2010). Likewise, the
American Cancer Society has warned about the harmful side
effects of chelation therapy. Moreover, loss of zinc can also lead
to mutations in cells, which may actually increase the risk of
cancer (Song et al., 2009). In summary, the reliability of chelation
therapies remains too controversial as to be considered the best
option (Nissen, 2013). Instead, the discovery of compounds that
specifically block the function of fungal proteins required for
counteracting host defense mechanisms and/or zinc acquisition
(e.g., ZafA and ZrfC) appears more promising. For instance, it
has been found recently an anti-mycobacterial compound that
interferes with zinc homeostasis by inactivating the countermea-
sures used by Mycobacterium to protect itself of the zinc-mediated
intoxication deployed by host phagocytes to kill it inside the
phagosomes (Rybniker et al., 2014). We await that a screening to
identify anti-Aspergillus compounds lead us to the discovery of
new drugs to block the regulation of zinc homeostasis and zinc
acquisition.
CONCLUSIONS AND OUTLOOK
The regulation of zinc homeostasis by ZafA and zinc acquisition
by ZrfC constitute highly promising therapeutic targets to combat
Aspergillus infections and perhaps also other infections caused
by fungal pathogens bearing similar targets. Furthermore, by
targeting two different steps (regulation of zinc homeostasis and
zinc acquisition) of the same biological process (zinc metabolism)
with a specific combination of two drugs we could get two of the
major achievements in the development of emerging antimicro-
bial therapies: (i) a synergistic interaction and, (ii) a significant
reduction in the probability of evolving mutations that enhance
the resistance of the fungus to any of these compounds (Cottarel
and Wierzbowski, 2007). Finally, to prevent the unavoidable
pleiotropic effect of chelators on host cells we propose that future
efforts to develop inhibitors for homeostasis of specific metals
in pathogens, including A. fumigatus, should be directed to the
discovery of compounds that specifically block the function of
microbial proteins required to regulate the homeostasis and/or
acquisition of metals.
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